Northland Capmk Weighs in on Astera Labs FY2026 Earnings

Astera Labs, Inc. (NASDAQ:ALAB - Free Report) - Investment analysts at Northland Capmk issued their FY2026 earnings estimates for Astera Labs in a research report issued on Thursday, January 2nd. Northland Capmk analyst G. Richard expects that the company will earn $0.71 per share for the year. Northland Capmk currently has a "Hold" rating on the stock. The consensus estimate for Astera Labs' current full-year earnings is ($0.45) per share.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its earnings results on Monday, November 4th. The company reported $0.23 EPS for the quarter, beating the consensus estimate of $0.17 by $0.06. Astera Labs had a negative return on equity of 15.57% and a negative net margin of 30.69%. The business had revenue of $113.10 million for the quarter, compared to the consensus estimate of $97.50 million. Astera Labs's quarterly revenue was up 47.1% on a year-over-year basis.

A number of other analysts also recently issued reports on ALAB. Roth Mkm raised their price target on shares of Astera Labs from $80.00 to $105.00 and gave the company a "buy" rating in a report on Tuesday, November 5th. Northland Securities downgraded shares of Astera Labs from an "outperform" rating to a "market perform" rating and lifted their target price for the stock from $100.00 to $120.00 in a research report on Thursday. Craig Hallum boosted their target price on shares of Astera Labs from $75.00 to $105.00 and gave the company a "buy" rating in a research note on Tuesday, November 5th. Citigroup began coverage on Astera Labs in a research note on Monday, November 18th. They issued a "buy" rating and a $120.00 price target on the stock. Finally, Morgan Stanley upped their price objective on Astera Labs from $94.00 to $142.00 and gave the company an "overweight" rating in a research report on Friday, December 20th. Two analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Astera Labs has a consensus rating of "Moderate Buy" and a consensus price target of $105.75.

Astera Labs Trading Up 1.9 %

Shares of Astera Labs stock traded up $2.71 during trading on Monday, hitting $143.64. 3,234,239 shares of the company's stock traded hands, compared to its average volume of 3,060,910. Astera Labs has a 1 year low of $36.22 and a 1 year high of $147.39. The business has a 50-day simple moving average of $111.04 and a 200-day simple moving average of $72.22.

Insider Buying and Selling

In other news, General Counsel Philip Mazzara sold 25,000 shares of the company's stock in a transaction dated Wednesday, October 9th. The stock was sold at an average price of $60.74, for a total value of $1,518,500.00. Following the completion of the transaction, the general counsel now owns 300,564 shares of the company's stock, valued at $18,256,257.36. This represents a 7.68 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Manuel Alba sold 11,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $117.50, for a total value of $1,292,500.00. Following the sale, the director now directly owns 456,863 shares in the company, valued at $53,681,402.50. This trade represents a 2.35 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,978,119 shares of company stock valued at $186,618,509.

Institutional Investors Weigh In On Astera Labs

Institutional investors have recently added to or reduced their stakes in the stock. Hollencrest Capital Management bought a new position in shares of Astera Labs during the third quarter worth $26,000. US Bancorp DE purchased a new stake in Astera Labs in the 3rd quarter worth $46,000. First Horizon Advisors Inc. bought a new position in shares of Astera Labs during the 3rd quarter valued at about $49,000. Allworth Financial LP grew its position in shares of Astera Labs by 445.5% during the third quarter. Allworth Financial LP now owns 1,091 shares of the company's stock valued at $57,000 after purchasing an additional 891 shares in the last quarter. Finally, GAMMA Investing LLC increased its holdings in shares of Astera Labs by 78.3% in the fourth quarter. GAMMA Investing LLC now owns 510 shares of the company's stock worth $68,000 after purchasing an additional 224 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.